These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30413609)

  • 1. NDRG3 overexpression is associated with a poor prognosis in patients with hepatocellular carcinoma.
    Jing JS; Li H; Wang SC; Ma JM; Yu LQ; Zhou H
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30413609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sperm-Associated Antigen 5 Expression Is Increased in Hepatocellular Carcinoma and Indicates Poor Prognosis.
    Zhou H; Wang SC; Ma JM; Yu LQ; Jing JS
    Med Sci Monit; 2018 Aug; 24():6021-6028. PubMed ID: 30157168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of NDRG3 associates with positive lymph node metastasis and unfavourable overall survival in laryngeal squamous cell carcinoma.
    Ma J; Liu S; Zhang W; Zhang F; Wang S; Wu L; Yan R; Wu L; Wang C; Zha Z; Sun J
    Pathology; 2016 Dec; 48(7):691-696. PubMed ID: 27780595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of NDRG3 associates with unfavorable overall survival in non-small cell lung cancer.
    Luo X; Hou N; Chen X; Xu Z; Xu J; Wang L; Yang S; Liu S; Xu L; Chen Y; Xiong L; Wang J; Fan W; Xu J
    Cancer Biomark; 2018 Feb; 21(2):461-469. PubMed ID: 29171988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
    Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
    BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3.
    Fan CG; Wang CM; Tian C; Wang Y; Li L; Sun WS; Li RF; Liu YG
    Oncol Rep; 2011 Nov; 26(5):1281-6. PubMed ID: 21725618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinoma.
    Li M; Luo RZ; Chen JW; Cao Y; Lu JB; He JH; Wu QL; Cai MY
    J Transl Med; 2011 Jan; 9():5. PubMed ID: 21205329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis.
    Wang F; Qiang Y; Zhu L; Jiang Y; Wang Y; Shao X; Yin L; Chen J; Chen Z
    Tumour Biol; 2016 Aug; 37(8):10235-46. PubMed ID: 26831666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of NDRG3 correlates with poor prognosis in gastric cancer patients.
    Liu Y; Xia J; Zhou Y; Shao S
    Rev Esp Enferm Dig; 2021 Jul; 113(7):524-528. PubMed ID: 33562989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SYPL1 overexpression predicts poor prognosis of hepatocellular carcinoma and associates with epithelial-mesenchymal transition.
    Chen DH; Wu QW; Li XD; Wang SJ; Zhang ZM
    Oncol Rep; 2017 Sep; 38(3):1533-1542. PubMed ID: 28731154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of CENP-H as a novel prognostic biomarker for human hepatocellular carcinoma progression and patient survival.
    Lu G; Shan T; He S; Ren M; Zhu M; Hu Y; Lu X; Zhang D
    Oncol Rep; 2013 Nov; 30(5):2238-44. PubMed ID: 23970101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of expression of Myc-induced nuclear antigen 53 in hepatocellular carcinoma and its relationship with patient prognosis].
    Ye DX; Zhou X; Yang Q; Hu XY; Li H; Xiang FG
    Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):259-265. PubMed ID: 32306660
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased expression of long noncoding RNA AK021443 predicts worse clinical outcome in hepatocellular carcinoma.
    Li YC; Wang D; Zhu GY
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4855-4860. PubMed ID: 30070318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma.
    Grinchuk OV; Yenamandra SP; Iyer R; Singh M; Lee HK; Lim KH; Chow PK; Kuznetsov VA
    Mol Oncol; 2018 Jan; 12(1):89-113. PubMed ID: 29117471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
    Cai L; Cai X
    Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.
    Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T
    Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of FOXQ1 oncogene overexpression in human hepatocellular carcinoma.
    Wang W; He S; Ji J; Huang J; Zhang S; Zhang Y
    Pathol Res Pract; 2013 Jun; 209(6):353-8. PubMed ID: 23623360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRG1 expression indicates unfavorable clinical outcome in hepatocellular carcinoma.
    Wang CH; Li M; Liu LL; Zhou RY; Fu J; Zhang CZ; Yun JP
    Oncotarget; 2015 Dec; 6(39):42118-29. PubMed ID: 26517349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.